The sensitive period for ototoxicity of kanamycin in mice: morphological evidence

Area of Science:

• Ototoxicology
• Developmental Biology
• Auditory Science

Background:

• Kanamycin is an aminoglycoside antibiotic with known ototoxic side effects.
• The developing auditory system may exhibit varying sensitivities to drug-induced damage.
• Understanding the ototoxicity of kanamycin is crucial for patient safety and therapeutic strategies.

Purpose of the Study:

• To investigate the ototoxicity of kanamycin in mice at different developmental stages.
• To identify the age-dependent vulnerability of the cochlea to kanamycin exposure.
• To determine the specific impact of kanamycin on outer-hair-cell (OHC) receptors.

Main Methods:

• Mice were administered kanamycin at three distinct age intervals: 6-9, 10-13, and 15-18 days.
• The cochlea of treated mice was examined for damage to outer-hair-cell (OHC) receptors.
• Histological analysis was performed to quantify the extent of ototoxic damage.

Main Results:

• Extensive damage to OHC receptors was observed in mice treated between 10 and 13 days of age.
• Less severe OHC damage was noted in the 6-9 day treatment group.
• Minimal cochlear damage was found in mice treated from 15 to 18 days of age.

Conclusions:

• The mouse cochlea exhibits peak vulnerability to kanamycin ototoxicity during rapid development, specifically between 10 and 13 days of age.
• Early developmental stages are critical periods for assessing drug-induced ototoxicity.
• These findings highlight the importance of age-specific drug administration and monitoring for ototoxic effects.